FIELD: medicine.
SUBSTANCE: invention refers to methods of in vitro detection of infection by Mycobacterium tuberculosis in mammals and to methods of in vitro differentiation of a Mycobacterium tuberculosis infected mammal suffering a latent form of tuberculosis, and a mammal suffering an active form of tuberculosis, and to a method of differentiation of a mammal suffering the active form of tuberculosis and a mammal non-infected by Mycobacterium tuberculosis, or a mammal who has the latent form of tuberculosis. The present invention also refers to kits for detection and differentiation of the infected mammal presenting tuberculosis symptoms, and the infected mammal with no disease development, and to a kit for distinction of a mammal suffering the active form of tuberculosis, and the mammal non-infected by Mycobacterium tuberculosis, or the mammal suffering the latent form of tuberculosis.
EFFECT: use of the methods and the kits under the present invention allows detecting in vitro the infected mammals with the active and latent forms of tuberculosis.
29 cl, 4 tbl, 15 dwg, 7 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR EVALUATING ACTIVITY OF TUBERCULOSIS INFECTION IN CHILDREN AND ADOLESCENTS | 2015 |
|
RU2586279C1 |
POLYANTIGENIC VACCINE FOR PREVENTING AND ADJUNCTIVE TREATMENT OF TUBERCULOSIS | 2019 |
|
RU2724896C1 |
DIAGNOSTIC TECHNIQUE FOR PULMONARY TUBERCULOSIS | 2012 |
|
RU2503005C1 |
RECOMBINANT PLASMIDE ENCODING HYBRID GST-ESAT-6 POLYPEPTIDE HAVING ACTIVITIES OF SPECIES-SPECIFIC MYCOBACTERIAL ESAT-6 ANTIGEN, RECOMBINANT ESCHERICHIA COLI STRAIN AS PRODUCER OF HYBRID GST-ESAT-6 POLYPEPTIDE AND RECOMBINANT GST-ESAT-6 POLYPEPTIDE | 2004 |
|
RU2282661C2 |
METHOD FOR PREDICTION OF DEVELOPING TUBERCULOSIS IN HEALTHY INDIVIDUALS | 2018 |
|
RU2707571C1 |
METHOD FOR DIAGNOSING TUBERCULOSIS AND DIFFERENTIAL DIAGNOSIS OF TUBERCULOSIS AND LATENT TUBERCULOSIS INFECTION | 2014 |
|
RU2576833C1 |
DIAGNOSTIC TECHNIQUE FOR TUBERCULOSIS INFECTION | 2012 |
|
RU2503006C1 |
METHOD FOR IMMUNOLOGICAL DETERMINATION OF TUBERCULOSIS INFECTION ACTIVITY IN CHILDREN AND ADOLESCENTS WITH LATENT INFECTION | 2020 |
|
RU2726789C1 |
METHOD OF DETERMINING ACTIVITY OF SPECIFIC INFLAMMATION WITH MINIMUM TUBERCULOSIS CHANGES IN CHILDREN AND ADOLESCENTS | 2019 |
|
RU2728943C1 |
BIOMARKERS FOR TUBERCULOSIS | 2014 |
|
RU2697549C2 |
Authors
Dates
2011-08-10—Published
2005-06-30—Filed